// App-Quantinova.ai

e15574 : Efficacy of an anti-EGFR after ctDNA conversion from mutated RAS status of metastatic colorectal cancer: Results of a pilot study.

Researchers

Presenter

  • Mohamed Bouchahda

Principal Investigators

  • Raphael Saffroy

  • Abdoulaye Karabou

  • Jocelyne Hamelin

  • Pasquale Innominato

  • Faouzi Saliba

  • Francis Levi

  • Nelly Bosselut

  • Antoinette Lemoine

Medical Centers

  • Clinique du Mousseau, Ramsay Générale de Santé, Evry, France

  • Oncogenetics Department, APHP, Universite´ Paris- Saclay, Paul Brousse Hospital, Villejuif, France

  • AK-SCIENCE, Vitry Sur Seine, France

  • BCUHB, Bangor, United Kingdom

  • Centre Hepato-Biliaire, AP-HP, Hopital Paul Brousse, Villejuif, France

  • Warwick University, Coventry, United Kingdom

  • Hopital Paul Brousse Biochemistry Department, University Paris-Sud, Villejuif, France

Locations

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Circulating DNA

  • RAS mutation

Drug/Treatment

  • Erbitux

  • FOLFIRI

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved